Docusign Envelope ID: D64265FD-5752-4188-9E5D-05D985B82C2F
| Arrhythmogenic Cardiomyopathy Trust | Arrhythmogenic Cardiomyopathy Trust | Arrhythmogenic Cardiomyopathy Trust | Arrhythmogenic Cardiomyopathy Trust | Arrhythmogenic Cardiomyopathy Trust | No(if any) | No(if any) | ||
|---|---|---|---|---|---|---|---|---|
| Receipts andpayments accounts | ||||||||
| For the period from |
01/01/2023 | To | 31/12/2023 | |||||
| Section A Receipts and payments | ||||||||
| Unrestricted funds |
Restricted funds | Endowment funds |
Total funds | |||||
| to the nearest £ | to the nearest £ | to the nearest £ | to the nearest £ | |||||
| A1 Receipts | ||||||||
| Income | 3,535 | - | - | 3,535 | ||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| Sub total_(Gross income for AR) _ | 3,535 |
- | - | 3,535 | ||||
| A2 Asset and investment sales, (see table). |
||||||||
| - 0 | - 0 | - 0 | - | |||||
| - 0 | - 0 | - 0 | - | |||||
| Sub total | - 0 |
- 0 | - 0 | - | ||||
| **Total receipts ** | 3,535 |
- 0 | - 0 | 3,535 | ||||
| A3 Payments | ||||||||
| Expenses | 137 | - | - | 137 | ||||
| Grants made | - 0 | - | - | - | ||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| - 0 | - | - | - | |||||
| **Sub total ** | 137 |
- | - | 137 | ||||
| A4 Asset and investment purchases,(see table) |
||||||||
| - 0 | - 0 | - 0 | - | |||||
| - 0 | - 0 | - 0 | - | |||||
| **Sub total ** | - 0 |
- 0 | - 0 | - | ||||
| **Totalpayments ** | 137 |
- 0 | - 0 | 137 | ||||
| **Net of receipts/(payments) ** | 3,398 |
- | - | 3,398 | ||||
| A5 Transfers between funds | - 0 | - | - | - | ||||
| A6 Cash funds lastyear end | 25,006 | - | - | 25,006 | ||||
| **Cash funds thisyear end ** | 28,404 |
- | - | 28,404 | ||||
| Section B Statement of assets and liabilities at the end of the period | ||||||||
| Categories | Details | Unrestricted funds |
Restricted funds | |||||
| to nearest £ | to nearest £ | |||||||
| B1 Cash funds | 28,404 | - | ||||||
| - | - | |||||||
| - | - |
CCXX R1 accounts (SS)
31/10/2020
1
Docusign Envelope ID: D64265FD-5752-4188-9E5D-05D985B82C2F
| Total cash funds | Total cash funds | Total cash funds | 28,404 | - | - | |||
|---|---|---|---|---|---|---|---|---|
| (agree balances with receipts and payments account(s)) |
OK | |||||||
| Unrestricted funds |
Restricted funds | |||||||
| Details | to nearest £ | to nearest £ | ||||||
| B2 Other monetary assets | - | - | ||||||
| - | - | |||||||
| - | - | |||||||
| - | - | |||||||
| - | - | |||||||
| - | - | |||||||
| Details | Fund to which asset belongs |
Cost (optional) | ||||||
| B3 Investment assets | - | |||||||
| - | ||||||||
| - | ||||||||
| - | ||||||||
| - | ||||||||
| Details | Fund to which asset belongs |
Cost (optional) | ||||||
| B4 Assets retained for the charity’s own use |
- | |||||||
| - | ||||||||
| - | ||||||||
| - | ||||||||
| - | ||||||||
| - | ||||||||
| - | ||||||||
| - | ||||||||
| - | ||||||||
| Details | Fund to which liability relates |
Amount due (optional) |
||||||
| B5 Liabilities | - | |||||||
| - | ||||||||
| - | ||||||||
| - | ||||||||
| - | ||||||||
| Signed by one or two trustees on behalf of all the trustees |
Signature | Print Name | ||||||
| James Minch | ||||||||
| Kate Minch | ||||||||
CCXX R2 accounts (SS)
31/10/2020
2
Docusign Envelope ID: D64265FD-5752-4188-9E5D-05D985B82C2F
CC16a Last year to the nearest £ - - - - - - - - - - 0 - 0 - 0 - - - - - - - - - - - 0 - 0 - - - - Endowment funds to nearest £ - - -
CCXX R3 accounts (SS)
31/10/2020
3
Docusign Envelope ID: D64265FD-5752-4188-9E5D-05D985B82C2F
- OK Endowment funds to nearest £ - - - - - - Current value (optional) - - - - - Current value (optional) - - - - - - - - - When due (optional) Date of approval 30.10.22
CCXX R4 accounts (SS)
31/10/2020
4